Activity

Jan Janisch-Hanzlik, Nebraska, Became The World’s First Multiple Sclerosis Patient To Receive Donor-Derived (DD) CAR T-Cell Therapy. After Standard Treatments Failed, She Joined A Phase-1 Trial Using DD T-Cells To Target Immune Cells Driving MS. Within 60 Days, Her Dramatic Progress Sparked Hope For Future MS Care & Potential Phase-2 Expansion.